Virtually screening antiviral compounds against SARS-CoV-2 structure may speed up drug and vaccine D

Virtually screening antiviral compounds to model their interactions with the SARS-CoV-2 virus may enable scientists to more easily identify antiviral drugs that work against the virus while informing the search for viable vaccine candidates, according to a new study. By screening for interactions with certain